Outcome of HSCT in Children at Ramathibodi Hospital
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 18
SponsorMahidol University
About this trial
Firstly, to study the treatment outcomes of hematopoietic stem cell transplantation (HSCT) in patients with hematologic diseases, cancers, and other conditions treated at the Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital. Secondly, to evaluate factors that may influence treatment outcomes in patients with hematologic diseases, cancers, and other conditions undergoing hematopoietic stem cell transplantation. Lastly, to study complications occurring after hematopoietic stem cell transplantation in patients with hematologic diseases, cancers, and other conditions, in order to identify opportunities to further improve treatment outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with hematologic, malignant, or other diseases who underwent HSCT
Disqualifiers
Incomplete or loss of medical records
Trial population
Patients in the Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University
Trial design
Design model
Case-only
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Overall survival
Time frame
5 years2
Disease free survival
Time frame
5 yearsSecondary outcomes
1
GVHD free rate
Time frame
5 years2
Infection rate
Time frame
5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov